Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 43.73 USD -0.32% Market Closed
Market Cap: 2.2B USD

Wall Street
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 67.43 USD with a low forecast of 55.55 USD and a high forecast of 77.7 USD.

Lowest
Price Target
55.55 USD
27% Upside
Average
Price Target
67.43 USD
54% Upside
Highest
Price Target
77.7 USD
78% Upside
Mirum Pharmaceuticals Inc Competitors:
Price Targets
4974
Takara Bio Inc
33% Upside
XGN
Exagen Inc
3% Upside
377740
BioNote Inc
17% Upside
086900
Medy Tox Inc
33% Upside
4893
Noile-Immune Biotech Inc
170% Upside
CPRX
Catalyst Pharmaceuticals Inc
41% Upside
ASMB
Assembly Biosciences Inc
152% Upside
ALVO
Alvotech SA
64% Upside

Revenue
Forecast

Revenue Estimate
Mirum Pharmaceuticals Inc

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 23%.

N/A
Past Growth
23%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MIRM's stock price target?
Price Target
67.43 USD

According to Wall Street analysts, the average 1-year price target for MIRM is 67.43 USD with a low forecast of 55.55 USD and a high forecast of 77.7 USD.

What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
23%

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 23%.

Back to Top